Related Experiment Video
Updated: Jul 15, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Detecting and treating primary aldosteronism: primary aldosteronism.
F Mantero1, M J Mattarello, N M E Albiger
1Division of Endocrinology, Department of Medical and Surgical Sciences, University of Padua, Italy. franco.mantero@unipd.it
Primary aldosteronism (PA), a common cause of hypertension, is increasingly detected using the plasma aldosterone concentration to plasma renin activity ratio (PAC/PRA). Early screening and diagnosis are crucial for managing hypertension and preventing cardiovascular damage.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Primary aldosteronism (PA) is the most prevalent cause of mineralocorticoid hypertension.
- Increased detection rates of PA are observed with the use of the plasma aldosterone concentration to plasma renin activity ratio (PAC/PRA) for screening hypertensive patients.
- Idiopathic bilateral adrenal hyperplasia (IHA) and aldosterone-producing adrenal adenoma (APA) are the primary causes of PA, with rarer forms including glucocorticoid-remediable aldosteronism (GRA) and carcinomas.
Purpose of the Study:
- To outline the diagnostic and management strategies for primary aldosteronism.
- To emphasize the importance of screening high-risk patients for PA.
- To differentiate between the subtypes of PA for appropriate treatment selection.
Main Methods:
- Screening for PA using the PAC/PRA ratio in patients with hypertension, hypokalemia, family history of early stroke, or resistant hypertension.
- Confirmation of diagnosis with sodium loading tests or captopril tests following a high PAC/PRA ratio.
- Subtype differentiation using adrenal gland imaging and adrenal venous sampling when necessary.
- Genetic testing for the detection of GRA.
Main Results:
- The PAC/PRA ratio has significantly increased the detection rate of PA.
- Adrenal gland imaging and adrenal venous sampling are key for differentiating APA from IHA.
- Genetic testing aids in identifying GRA.
- Surgical intervention is the preferred treatment for APA, while medical management is used for IHA.
Conclusions:
- Early screening and accurate diagnosis of PA are essential for managing hypertension and preventing associated complications.
- Treatment strategies, including surgery for APA and medical therapy for IHA, aim to normalize aldosterone levels or block its effects.
- Effective management of PA reduces the morbidity and mortality linked to hypertension, hypokalemia, and cardiovascular damage.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hormonal Regulation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension and Regulation of Blood Pressure